FSPKF OTC
Fisher & Paykel Healthcare Corporation Limited
1W: +1.6%
1M: -2.0%
3M: +15.5%
YTD: +35.0%
1Y: +24.9%
3Y: +114.8%
5Y: +23.9%
$26.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$670M
+22.1% ▲
5Y CAGR: +1.4%
Capital Expenditures
$175M
-69.4% ▼
5Y CAGR: -1.1%
Free Cash Flow
$495M
+11.2% ▲
5Y CAGR: +2.4%
Dividends Paid
$255M
-30.1% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
$202M
+12.5% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $377M | $250M | $133M | $0 | $473M |
| Depreciation & Amort. | $96M | $99M | $114M | $0 | $160M |
| Stock-Based Comp. | $8M | $9M | $11M | $0 | $0 |
| Change in Working Capital | -$42M | -$69M | $7M | -$68M | $16M |
| Other Non-Cash Items | $133M | $220M | $165M | $616M | $24M |
| Operating Cash Flow | $324M | $238M | $430M | $549M | $670M |
| — Investing Activities — | |||||
| Capital Expenditures | -$170M | -$211M | -$317M | -$74M | -$197M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $80M | $200M | $0 | $0 | $0 |
| Other Investing | $45M | $165M | -$22M | -$29M | $0 |
| Investing Cash Flow | -$90M | -$11M | -$339M | -$103M | -$197M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$100K | $10M | $31M | -$57M | -$7M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$225M | -$196M | -$146M | -$196M | -$255M |
| Other Financing | -$14M | -$14M | -$17M | -$18M | -$22M |
| Financing Cash Flow | -$236M | -$197M | -$129M | -$268M | -$279M |
| Net Change in Cash | -$800K | $32M | -$36M | $179M | $202M |
| Cash End of Period | $85M | $117M | $81M | $260M | $466M |
| Free Cash Flow | $154M | $27M | $91M | $446M | $495M |